SBI Securities’s Health Catalyst HCAT Stock Holding History
Bought
Maintained
Sold
Other funds holding HCAT
FLAM
CF
WCA
PVM
VCM
NI
SBI Securities's HCAT Position: Q1 2026 in Review
SBI Securities reduced its Health Catalyst (HCAT) stake by 6.4% in Q1 2026, selling an estimated $158 and leaving 1,226 shares worth $1.56K. The position accounts for ﹤0.01% of the portfolio, ranked #2494.
SBI Securities first reported a position in HCAT in Q4 2024 and has held it in 6 quarters since. The position peaked at $9.54K in Q4 2024. 130 funds tracked by Wall St. Rank hold HCAT as of Q1 2026.
- SBI Securities held 1,226 shares of Health Catalyst worth $1.56K as of Q1 2026.
- SBI Securities sold 84 Health Catalyst shares in Q1 2026, an estimated $158.
- Health Catalyst made up ﹤0.01% of SBI Securities's portfolio in Q1 2026, its #2494 holding.
- SBI Securities first reported a position in Health Catalyst in Q4 2024 and has held it in 6 quarters since.
- SBI Securities's Health Catalyst position peaked at $9.54K in Q4 2024.
- 130 funds tracked by Wall St. Rank held Health Catalyst as of Q1 2026.
Based on SBI Securities's 13F filing for Q1 2026, filed 28 Apr 2026.